Imperial Announces Voting Results for the Election of Directors

VANCOUVER, British Columbia, May 23, 2024 (GLOBE NEWSWIRE) -- Imperial Metals Corporation (“Imperial” or the “Company”) (TSX: III) reports, in accordance with the policies of the Toronto Stock Exchange, that the nominees listed in the management information circular dated April 5, 2024, were elected as directors of the Company at the Company’s virtual Annual General Meeting of Shareholders held on May 22, 2024 (the "Meeting").

Results of the vote for the election of directors which took place at the Meeting are:

Name		Votes For	%		Votes Withheld	%
Carolyn D. Anglin		115,311,031	98.69		1,526,537	1.31
J. Brian Kynoch		116,822,129	99.99		15,439	0.01
Pierre Lebel		113,470,640	97.12		3,366,928	2.88
Larry G. Moeller		116,822,128	99.99		15,440	0.01
Janine North		116,804,482	99.97		33,086	0.03
James P. Veitch		116,803,962	99.97		33,606	0.03
Edward A. Yurkowski		116,714,594	99.89		122,974	0.11

A total of 117,042,544 common shares were voted in connection with the Meeting, representing approximately 72.30% of the issued and outstanding common shares of the Company. The results of other matters considered at the Meeting are reported in the Report of Voting Results, filed on SEDAR+ under the Company's profile at www.sedarplus.com.

About Imperial

Imperial is a Vancouver based exploration, mine development and operating company with holdings that include the Mount Polley mine (100%), the Huckleberry mine (100%), and the Red Chris mine (30%). Imperial also holds a portfolio of 23 greenfield exploration properties in British Columbia. These properties have defined areas of mineralization and clear exploration potential. Management continues to evaluate various opportunities to advance many of these properties.

Company Contacts

Brian Kynoch | President | 604.669.8959

Source: Imperial Metals Corporation

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Prelude Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
• NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Begins Training and Deployment of Zeta Surgical's FDA-Cleared Robotic TMS System
• Spectral Medical Provides Update Following In-Person FDA 100-Day Meeting for PMX PMA